SeekingAlpha · Aug 31, 2026
Materialise: A High-Margin Medical Business Hiding In Plain Sight
Materialise outlook: Medical drives strong growth, Manufacturing rebounds, Software risk rises. Click for more on MTLS stock.
NASDAQ · MTLS
Technology · Software - Application
$7.64
Up+$0.21 (+2.83%)
Updated Sep 13, 2026, 12:44 AM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
MTLS closed at $7.64 after 20 trading sessions, up 10.40% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $7.45 | $7.72 | $7.36 | $7.64 | 369.18K |
| Sep 10, 2026 | $7.40 | $7.55 | $7.40 | $7.43 | 74.97K |
| Sep 9, 2026 | $7.55 | $7.59 | $7.40 | $7.46 | 111.52K |
| Sep 8, 2026 | $7.46 | $7.67 | $7.37 | $7.56 | 215.42K |
| Sep 4, 2026 | $7.02 | $7.60 | $7.00 | $7.46 | 258.21K |
| Sep 3, 2026 | $7.12 | $7.14 | $7.015 | $7.03 | 89.87K |
| Sep 2, 2026 | $7.09 | $7.1899 | $7.05 | $7.07 | 61.95K |
| Sep 1, 2026 | $7.12 | $7.22 | $7.045 | $7.06 | 141.44K |
| Aug 31, 2026 | $7.00 | $7.285 | $6.99 | $7.21 | 148.13K |
| Aug 28, 2026 | $7.42 | $7.48 | $6.97 | $7.02 | 241.38K |
| Aug 27, 2026 | $7.20 | $7.445 | $6.91 | $7.42 | 499.34K |
| Aug 26, 2026 | $6.49 | $6.71 | $6.47 | $6.67 | 87.88K |
| Aug 25, 2026 | $6.70 | $6.725 | $6.45 | $6.47 | 86.84K |
| Aug 24, 2026 | $6.60 | $6.70 | $6.51 | $6.69 | 115.47K |
| Aug 21, 2026 | $6.54 | $6.63 | $6.54 | $6.61 | 41.78K |
| Aug 20, 2026 | $6.57 | $6.66 | $6.46 | $6.51 | 76.44K |
| Aug 19, 2026 | $6.67 | $6.7674 | $6.52 | $6.57 | 108.04K |
| Aug 18, 2026 | $6.67 | $6.78 | $6.67 | $6.69 | 52.5K |
| Aug 17, 2026 | $6.86 | $6.89 | $6.7132 | $6.73 | 63.47K |
| Aug 14, 2026 | $6.84 | $6.92 | $6.78 | $6.92 | 71.83K |
The latest Smart Investors Daily articles mentioning MTLS.
MTLS research
Company profile and research snapshot.
Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| May 6, 2026 | CANTOR FITZGERALD | Overweight | — |
| Feb 19, 2026 | CANTOR FITZGERALD | Overweight | — |
| Feb 3, 2025 | KBC SECURITIES | Buy | — |
| Oct 24, 2024 | LAKE STREET CAPITAL MARKETS | Buy | — |
No generated briefing is available yet.
SeekingAlpha · Aug 31, 2026
Materialise outlook: Medical drives strong growth, Manufacturing rebounds, Software risk rises. Click for more on MTLS stock.
Yahoo · Aug 31, 2026
Medical revenue surged 9.6% while management raised full-year profit guidance.
Benzinga · Aug 28, 2026
SEC.
Yahoo · Aug 28, 2026
European equities traded in the US as American depositary receipts were marginally higher late Frida
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning MTLS.